News | December 21, 2024
Lonza expands capsule manufacturing capacity in India and China
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari and Suzhou
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari and Suzhou
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Harnessing advanced data analysis for early detection, prevention and better outcomes
Showing High Overall Response Rate (ORR) with durable responses and favorable safety profile in patients with heavily pretreated multiple myeloma
GSK secures option to multiple high-value, validated Alzheimer’s-relevant targets for drug discovery, development, and commercialization
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
Subscribe To Our Newsletter & Stay Updated
